Nyse jnj compare.
Johnson & Johnson ( JNJ 0.32%) is transforming, and it's the transformation that could propel this Dow stock higher in 2023 and beyond. Until a couple of months ago, Johnson & Johnson was making ...
Overview Key Ratios Peer Comparison Financials Share Holdings Other details Johnson & Johnson (JNJ) Share Price NYSE $151.28 As on 27-Nov-2023 16:10 …Get the latest stock price, news, analysis and financial data for Johnson & Johnson (JNJ) on the Mexican Stock Exchange (BMV). Compare JNJ with other companies in the …Relative valuation technique determine the value of Johnson & Johnson by comparing it to similar entities (like industry or sector) on the basis of several ...(NYSE: JNJ) Johnson & Johnson's current Earnings Per Share (EPS) is $13.61. On average, analysts forecast that JNJ's EPS will be $10.10 for 2023, with the lowest EPS forecast at $10.05, and the highest EPS forecast at $10.15. On average, analysts forecast that JNJ's EPS will be $10.81 for 2024, with the lowest EPS forecast at $10.30, and the ...
December 4, 2023. Lbp Am Sa raised its holdings in shares of Johnson & Johnson ( NYSE:JNJ - Free Report) by 12.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 469,878 shares of the company's stock after purchasing an additional 53,468 shares …२०२३ अगस्ट ६ ... ... compare?) 3:06 KVUE is 15.4% off its 52-week high, that said IPOs can have volatility. 3:26 Forward PE Comparison: JNJ is trading at a ...Nov 7, 2022 · The Street’s Moderate Buy consensus rating on Johnson & Johnson stock is based on four Buys and seven Holds. At $181.60, the average JNJ stock price prediction suggests 5% upside potential.
Open Int (30-Day): The average total open interest for all option contracts (across all expiration dates) for the last 30 days. Johnson & Johnson stocks price quote with latest …The Dividend Yield % of Johnson & Johnson (JNJ) is 3.08% (As of Today), Highest Dividend Payout Ratio of Johnson & Johnson (JNJ) was 5.3. The lowest was 0.48. And the median was 0.56. The Forward Dividend Yield % of Johnson & Johnson (JNJ) is 3.12%. For more information regarding to dividend, please check our Dividend Page .
Overview Key Ratios Peer Comparison Financials Share Holdings Other details Johnson & Johnson (JNJ) Share Price NYSE $151.28 As on 27-Nov-2023 16:10 …Feb 14, 2023 · NYSE: JNJ Johnson & Johnson. Market Cap. $372B. Today's Change (0.74%) $1.14. ... Johnson & Johnson (JNJ 0.74%) and AbbVie (ABBV 0.35%) are two of the bigger names in healthcare stocks. The ... Johnson & Johnson announced its 61st consecutive dividend increase and it raised its 2023 outlook along with beating top and bottom line estimates. Find out why JNJ stock is a Buy.JNJ Earnings Date and Information. Johnson & Johnson last announced its quarterly earnings data on October 17th, 2023. The reported $2.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.52 by $0.14. The business had revenue of $21.35 billion for the quarter, compared to analysts' …Nov 7, 2022 · The Street’s Moderate Buy consensus rating on Johnson & Johnson stock is based on four Buys and seven Holds. At $181.60, the average JNJ stock price prediction suggests 5% upside potential.
Dec 1, 2023 · JNJ Earnings Date and Information. Johnson & Johnson last announced its quarterly earnings data on October 17th, 2023. The reported $2.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.52 by $0.14. The business had revenue of $21.35 billion for the quarter, compared to analysts' expectations of $21 billion.
170 B $. AMGEN INC. +0.62%. 141 B $. Equities. Stock Johnson & Johnson - Nyse. Johnson & Johnson (JNJ.NYSE) : Stock quote, stock chart, quotes, analysis, advice, …
Teleflex stock (NYSE: TFX), which provides instruments and consumables for laboratories, trades at $220 per share, 50% below the level seen in March 2021. TFX …But Johnson & Johnson ( NYSE:JNJ) has fallen short of that second goal, with a share price rise of 28% over five years, which is below the market return. Zooming in, the stock is actually down 7.8 ...New Brunswick, N.J. (October 18, 2022) – Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2022. “Our third quarter performance demonstrates our continued strength and resilience across all three of our businesses,” said Joaquin Duato, Chief Executive Officer. “Through the ongoing efforts of our teams around the ...Nov 30, 2023 · J&J stock price quote (NYSE: JNJ), historical charts, related news, stock analyst insights and more to help you make the right investing decisions. Johnson & Johnson has increased its dividend for the past 61 consecutive years. When did Johnson & Johnson last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $0.06 on Tuesday, April 18, 2023.As such, its total long-term debt to capitalization ratio is also higher at 36.9% Vs. J&J’s 27.6%. J&J’s interest coverage in the trailing 12 months is 25.69x, much better than Pfizer’s 9 ...
Dec. 1, 2023, 01:05 PM. UBS has upgraded Johnson & Johnson (NYSE:JNJ), citing a bullish view of the company's pharmaceutical business and expectations for MedTech growth that align with the market ...Johnson & Johnson (NYSE:JNJ) CFO Joseph Wolk and pharmaceuticals division head Jennifer Taubert are reportedly leading contenders for the CEO job in the …Johnson & Johnson's Q1 2023 revenue reached $24.75 billion but the share price has declined by 13.38% since the beginning of the year. Find out why JNJ stock is a Hold.Dec 1, 2023 · Johnson & Johnson Stock Price, News & Analysis (NYSE:JNJ) $154.56 +2.45 (+1.61%) (As of 12:45 PM ET) Compare Today's Range $151.92 $154.58 50-Day Range $145.62 $161.66 52-Week Range $144.95 $181.04 Volume 2.76 million shs Average Volume 11.49 million shs Market Capitalization $372.07 billion P/E Ratio 11.47 Dividend Yield 3.08% Price Target NEW BRUNSWICK, N.J., November 30, 2023--Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib). Johnson ...
Webull offers JNJ Ent Holdg (JNJ) historical stock prices, in-depth market analysis, NYSE: JNJ real-time stock quote data, in-depth charts, free JNJ options chain data, and a fully built financial calendar to help you invest smart. Buy JNJ stock at Webull.2. $JNJ - almost time to enter Looking at the chart dating back 5 years for NYSE:JNJ , there is a decent entry point around $150. Looking for a slight drop in current price to enter. Entry point will follow along the 5 year …
We believe Bristol Myers Squibb stock (NYSE: BMY) is a better pick than its industry peer, Johnson & Johnson (NYSE: JNJ). J&J trades at a higher valuation of 4.4x trailing revenues, compared to 3 ...Johnson & Johnson (NYSE: JNJ). $158.38. (2.4%). $3.72. Price as of December 1 ... compared to the earnings before interest, taxes, depreciation, and amortization ...Get the latest stock price, news, analysis and financial data for Johnson & Johnson (JNJ) on the Mexican Stock Exchange (BMV). Compare JNJ with other companies in the …NYSE: JNJ Johnson & Johnson. Market Cap. $364B. Today's Change (0.03%) $0.05. Current Price. ... Two giants in the space are Johnson & Johnson (JNJ 0.03%) and Medtronic (MDT-0.17%). They bring in ...So, let's check out these top dividend stocks to own in 2023. 1. Johnson & Johnson. Johnson & Johnson ( JNJ -0.20%) will pay you $4.52 a share annually just for being a shareholder. That means if ...2. $JNJ - almost time to enter Looking at the chart dating back 5 years for NYSE:JNJ , there is a decent entry point around $150. Looking for a slight drop in current price to enter. Entry point will follow along the 5 year …
CatLane/iStock Unreleased via Getty Images. Johnson & Johnson (NYSE:JNJ) for years has been a safety net for many dividend investors, and that continues to be the case in 2022.In a year in which ...
December 1, 2023. London Co. of Virginia lessened its stake in shares of Johnson & Johnson ( NYSE:JNJ - Free Report) by 2.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,643,775 shares of the company's stock after selling 58,569 ...
JNJ is currently trading c.34% higher than the estimated price, hence is overvalued. That being said, JNJ is also known for beating analysts’ estimates. In the last 2 years, JNJ beat analysts ...Oct 31, 2023 · Stelara's total sales were $2,864 million in Q3 2023, an increase of 16.9% year-over-year. The company's management raised its financial guidance for full-year 2023 adjusted-diluted EPS from $10 ... In this article, we will take a closer look at Johnson & Johnson (NYSE:JNJ) and Pfizer , the two largest US-based pharmaceutical companies by market capitalization. Both are high-quality dividend ...1Y. Mkt Cap. P/E. Growth. Strong dividend paying companies in the US market. View Management. Johnson & Johnson (NYSE:JNJ) dividend yield is 3.1%. Dividend payments have increased over the last 10 years and are covered by earnings with a payout ratio of 85.7%.This report compares the performances of Johnson & Johnson (JNJ) and GlaxoSmithKline PLC (GSK) stocks. After reading this report, you will learn the differences in growth, annual returns, dividend payouts, splits, biggest gains etc. The timeframe of analysis is between '11-26-2013' and '11-24-2023'. In total, there are 7 sections in this report.Stock analysis for Johnson & Johnson (JNJ:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Johnson & Johnson ( NYSE: JNJ) is a legendary healthcare company with a renewed focus on its pharmaceutical and medtech segments, making it an excellent defensive pick. The recent selloff in JNJ ...Johnson & Johnson satisfies all the requirements that Benjamin Graham promoted for picking defensive stocks. Notably, it’s also trading at a sizable discount from the overall market and also the ...२०२० अप्रिल २४ ... ... JNJ stock to see which Dividend Aristocrat companies is the best ... Stock Market Crash https://youtu.be/2ZYpSIwCKWc.Quarterly results prove Johnson & Johnson remains a top pick in a frothy market. Remicade sales are down, but that is a marginal issue, it seems.Johnson & Johnson (NYSE: JNJ) Third place goes to Johnson & Johnson (NYSE: JNJ), a pharmaceutical giant whose share price declined by 11% in the past twelve months, significantly underperforming the market return of 14%. However, the stock has shown a positive trend, rising by 6.3% over the past three years.Price-To-Earnings vs Fair Ratio: JNJ is good value based on its Price-To-Earnings Ratio (26.6x) compared to the estimated Fair Price-To-Earnings Ratio (29x). Analyst Price Targets What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Johnson & Johnson Stock Price, News & Analysis (NYSE:JNJ) $154.56 +2.45 (+1.61%) (As of 12:45 PM ET) Compare Today's Range $151.92 $154.58 50-Day Range …Aug 17, 2023 · RyanJLane. One of the most popular requests from Dividend Kings members is to compare Johnson & Johnson (NYSE:JNJ) and Kenvue Inc. (NYSE:KVUE).. Here is what you need to know about both companies ... The Street’s Moderate Buy consensus rating on Johnson & Johnson stock is based on four Buys and seven Holds. At $181.60, the average JNJ stock price prediction suggests 5% upside potential.Instagram:https://instagram. teladoc revenueotcmkts nvnxfgoogl target pricebest day trading chat rooms २०२३ मार्च ९ ... Johnson & Johnson(NYSE:JNJ): With the Fed anticipating higher ... compared to the negative 3.99% industry average. POWR Ratings Show Promise. usb nysewhich dental insurance is best A high-level overview of Johnson & Johnson (JNJ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. stock research websites After an 11.22% decline in its share price over the past year, the average JNJ price target of $176.38 per share implies 14.16% upside potential. Disclosure. …The latest price target for Johnson & Johnson ( NYSE: JNJ) was reported by RBC Capital on Friday, December 1, 2023. The analyst firm set a price target for 178.00 expecting JNJ to rise to within ...